Latest News & Features
Americas
Anyone seeking a deal with a life sciences company must understand the value and potential risks of its IP, as Karen Mangasarian and Ryan Murphey of Ropes & Gray explain. 6 December 2016
Americas
Oral arguments in Life Technologies v Promega are due to take place tomorrow in the US Supreme Court to determine whether the US Court of Appeals for the Federal Circuit correctly defined “substantial portion”. 5 December 2016
Americas
The US Court of Appeals for the Federal Circuit has affirmed rulings in a patent dispute which saw Leica Biosystems Melbourne Party succeed in two inter partes re-examinations against patents belonging to Dako Denmark. 5 December 2016
Americas
Forest Laboratories, Allergan and Ironwood Pharmaceuticals have filed a complaint against Teva, Mylan, Sandoz and Aurobindo for alleged patent infringement. 2 December 2016
article
Pharmaceutical company Mallinckrodt has filed a complaint against Mylan for alleged patent infringement over its drug Ofirmev, a treatment for fever. 2 December 2016
Americas
Merck has filed a complaint against Strides Pharma for alleged patent infringement over Sustiva, an antiviral medication that prevents HIV from multiplying in the human body. 1 December 2016
Americas
An interference proceeding on the patent rights to CRISPR/Cas9 will take place on December 6, with the judges setting the definition of the disputed invention as “the use of CRISPR in a method in a eukaryotic cell”. 1 December 2016
Europe
Law firm HGF has hired a new patent director, Martin Connors, who will start tomorrow. 30 November 2016
Americas
A US district court has dismissed a patent infringement lawsuit between US-based biotechnology company Genzyme and Mylan Pharmaceuticals after the companies agreed to settle. 30 November 2016
Big Pharma
UK life sciences organisations are still uncertain about the implications of Britain’s departure from the EU, despite welcoming the announcement that the UK will ratify the Unified Patent Court Agreement. 30 November 2016